Valuation check: SIBN's profit margin is -6.85%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
SI-BONE's profit margin stands at -6.85% as of June 2026. That compares with -12.83% in the prior-year period — up 46.6% year over year. That is below the Healthcare sector average of 13.89%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
SI-BONE reported -6.85% in profit margin versus -12.83% a year earlier — a 46.6% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.
SI-BONE sits lower the Healthcare benchmark (13.89%) with a profit margin of -6.85%. That is roughly 149.3% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A profit margin of -6.85% for SI-BONE means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how SI-BONE's profit margin evolved across reporting periods, while the comparison chart places SIBN next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.